Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity

Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity

Doxorubicin (DOX) is a well-known chemotherapeutic agent extensively applied in the field of cancer therapy. However, similar to other chemotherapeutic agents such as cisplatin, paclitaxel, docetaxel, etoposide and oxaliplatin, cancer cells are able to obtain chemoresistance that limits DOX efficacy...

Full description

Bibliographic Details
Main Authors: Milad Ashrafizadeh, Ali Zarrabi, Farid Hashemi, Amirhossein Zabolian, Hossein Saleki, Morteza Bagherian, Negar Azami, Atefe Kazemzade Bejandi, Kiavash Hushmandi, Hui Li Ang, Pooyan Makvandi, Haroon Khan, Alan Prem Kumar
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Pharmaceutics
Subjects:
doxorubicin
curcumin
chemoresistance
side effect
apoptosis
nanodelivery
Online Access:https://www.mdpi.com/1999-4923/12/11/1084

Internet

https://www.mdpi.com/1999-4923/12/11/1084

Similar Items